Yogi gets ready to tackle Black Fungus in UP
By IANS |
2 Views
Yogi Adityanath. (File Photo: IANS). Image Source: IANS News
Lucknow, May 13 : Uttar Pradesh Chief Minister Yogi Adityanath has started making efforts to curb the spread of deadly Black Fungus at its initial stage.
A few cases of this rare and fatal disease have been found among recovered and recovering Covid-19 patients.
Though the cases of this deadly disease are very rare in the state, its lethality has prompted the Yogi Government to issue warnings and put doctors on a high alert.
The chief minister has directed the 14-member health expert committee to tackle this situation.
UP news: bijnor dy sp ganesh kumar gupta latest news update: बिजनौर सीओ गणेश कुमार गुप्ता न्यूज अपडेट
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
मध्य प्रदेश में काला फंगस, 13 नए मामलों के साथ 2 लोगों की गई जान
newstracklive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newstracklive.com Daily Mail and Mail on Sunday newspapers.
Uttar Pradesh Coronavirus Cases Latest Update । 326 Corona Patients Died In 24 Hours In Uttar Pradesh Lucknow Agra Meerut Varanasi | 29 दिन बाद नए केस 20 हजार से कम, लेकिन मौतें नहीं थम रहीं; 45+ वालों के लिए फिर से ऑनस्पॉट वैक्सीनेशन की तैयारी
bhaskar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bhaskar.com Daily Mail and Mail on Sunday newspapers.
Industry > Industry monitor > Healthcare
29 April 2021
Ayush 64, a poly-herbal preparation originally developed by the Central Council for Research in Ayurvedic Sciences (CCRAS) for the treatment of Malaria, in the year 1980 and now repurposed for the treatment Covid-19, has been found to be useful in the treatment of asymptomatic, mild and moderate Covid-19 infection as an adjunct to standard care.
Ministry of Ayush and the Council of Scientific and Industrial Research (CSIR) recently collaborated for robust multi-centre clinical trials to evaluate the safety and efficacy of Ayush 64 in the management of mild to moderate Covid-19 patients.
Clinical trials were conducted at KGMU, Lucknow; DMIMS, Wardha and BMC Covid Centre, Mumbai, involving 70 participants in each arm. Dr Chopra said Ayush 64 as an adjunct to standard of care (SoC) showed significant improvement and thus lesser period of hospitalisation compared to the only SoC procedure, Dr Arvind Chopra, director, Centre for R